Enfusion Inc.

NYSE: ENFN · Real-Time Price · USD
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM

Enfusion Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.48M 35.6M 62.55M 64.36M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
10.71M 6.5M 4.48M 3.36M
Receivables
31.99M 28.07M 25.86M 18.22M
Inventory
n/a n/a 6.11M n/a
Other Current Assets
7.05M 1.17M 2.3M 7.09M
Total Current Assets
93.52M 69.85M 96.81M 89.68M
Property-Plant & Equipment
39.02M 32.62M 22.49M 13.05M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
49.74M 39.12M 26.98M 16.41M
Total Assets
143.26M 108.97M 123.78M 106.08M
Account Payables
867K 2.21M 1.69M 2.53M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
6.08M n/a 4.03M n/a
Other Current Liabilities
20.39M 10.06M 6.24M 2.4M
Total Current Liabilities
27.34M 20.31M 17.38M 8.11M
Long-Term Debt
14.24M n/a n/a n/a
Other Long-Term Liabilities
2.15M n/a n/a 538K
Total Long-Term Liabilities
16.39M 11.18M 2.96M 538K
Total Liabilities
43.72M 31.49M 20.34M 8.64M
Total Debt
20.31M 15.44M 6.99M n/a
Common Stock
129K 127K 114K 113K
Retained Earnings
-170.11M -172.93M -178.86M -328K
Comprehensive Income
-734K -406K -504K -171.21M
Shareholders Equity
73.22M 53.67M 65.01M 55.29M
Total Investments
n/a n/a n/a n/a